Neuroprotective Mechanisms of Glucagon-Like Peptide-1-Based Therapies in Ischaemic Stroke: A Systematic Review Based on Pre-Clinical Studies

Basic and Clinical Pharmacology and Toxicology - United States
doi 10.1111/bcpt.12974
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies

Gastroenterology
HepatologyGastroenterology
2011English

Does Glucagon-Like Peptide-1 Ameliorate Oxidative Stress in Diabetes? Evidence Based on Experimental and Clinical Studies

Current Diabetes Reviews
EndocrinologyMetabolismDiabetes
2016English

Normobaric Hyperoxia-Based Neuroprotective Therapies in Ischemic Stroke

Medical Gas Research
NeuroscienceAnesthesiologyPain Medicine
2013English

Glucagon-Like Peptide-1 and Satiety

Nature
Multidisciplinary
1997English

Effects of Gastric Inhibitory Polypeptide, Glucagon-Like Peptide-1 and Glucagon-Like Peptide-1 Receptor Agonists on Bone Cell Metabolism

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Thrombophilia and First Arterial Ischaemic Stroke: A Systematic Review

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2005English

Administration of Thiazolidinediones for Neuroprotection in Ischemic Stroke: A Pre-Clinical Systematic Review

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2010English

Pdb12 - Cardiovascular Safety of Empagliflozin Versus Glucagon-Like Peptide-1 (Glp-1) Receptor Agonists: Systematic Literature Review and Indirect Comparisons

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Equine Glucagon-Like Peptide-1 Receptor Physiology

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy